Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Plant Preparations | 1 | 2020 | 276 | 0.65 | Why? |
| Plants, Medicinal | 1 | 2020 | 622 | 0.54 | Why? |
| Smoking | 5 | 2020 | 3358 | 0.42 | Why? |
| Propensity Score | 3 | 2017 | 2690 | 0.41 | Why? |
| Bias | 1 | 2014 | 1109 | 0.35 | Why? |
| Pulmonary Medicine | 1 | 2014 | 706 | 0.34 | Why? |
| England | 10 | 2021 | 5116 | 0.30 | Why? |
| Asthma | 4 | 2020 | 4383 | 0.29 | Why? |
| Clinical Coding | 1 | 2021 | 172 | 0.20 | Why? |
| Cerebral Palsy | 1 | 2021 | 156 | 0.20 | Why? |
| Models, Statistical | 2 | 2014 | 5312 | 0.20 | Why? |
| Medical History Taking | 1 | 2021 | 350 | 0.18 | Why? |
| Anti-Infective Agents, Urinary | 1 | 2018 | 27 | 0.18 | Why? |
| Osteoarthritis | 1 | 2021 | 205 | 0.18 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.18 | Why? |
| Nurse Specialists | 1 | 2018 | 82 | 0.18 | Why? |
| Proportional Hazards Models | 5 | 2021 | 6543 | 0.17 | Why? |
| Cohort Studies | 11 | 2021 | 36005 | 0.17 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2018 | 170 | 0.16 | Why? |
| Research Design | 1 | 2014 | 5830 | 0.16 | Why? |
| DNA End-Joining Repair | 1 | 2016 | 4 | 0.16 | Why? |
| DNA Breaks, Double-Stranded | 1 | 2016 | 17 | 0.16 | Why? |
| Hyperkalemia | 1 | 2018 | 140 | 0.16 | Why? |
| Down Syndrome | 1 | 2021 | 397 | 0.16 | Why? |
| Translocation, Genetic | 1 | 2016 | 40 | 0.16 | Why? |
| Teaching Rounds | 1 | 2018 | 208 | 0.15 | Why? |
| Infectious Disease Medicine | 1 | 2018 | 311 | 0.14 | Why? |
| Tasmania | 1 | 2014 | 59 | 0.14 | Why? |
| Phytotherapy | 1 | 2020 | 743 | 0.13 | Why? |
| Mortality | 3 | 2020 | 7132 | 0.12 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2018 | 433 | 0.12 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Hospital Units | 1 | 2018 | 1017 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 1454 | 0.11 | Why? |
| Alzheimer Disease | 1 | 2021 | 1020 | 0.11 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| Disabled Persons | 1 | 2021 | 1152 | 0.10 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.10 | Why? |
| State Medicine | 2 | 2021 | 2847 | 0.10 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.09 | Why? |
| Cardiovascular System | 1 | 2017 | 750 | 0.09 | Why? |
| Dietary Supplements | 1 | 2020 | 2251 | 0.09 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.09 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.08 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.08 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.08 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.08 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.08 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.07 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.07 | Why? |
| Adult | 12 | 2021 | 244371 | 0.07 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.07 | Why? |
| Humans | 25 | 2021 | 930598 | 0.07 | Why? |
| Male | 16 | 2021 | 367725 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.07 | Why? |
| Female | 16 | 2021 | 380317 | 0.07 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Aging | 1 | 2020 | 3581 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.06 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.06 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.05 | Why? |
| Vitamin D | 1 | 2016 | 2904 | 0.05 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.05 | Why? |
| Multilevel Analysis | 1 | 2018 | 104 | 0.05 | Why? |
| Muscarinic Antagonists | 1 | 2020 | 176 | 0.05 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.04 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Sierra Leone | 1 | 2018 | 267 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.04 | Why? |
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2016 | 76 | 0.04 | Why? |
| Wales | 1 | 2018 | 758 | 0.04 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.04 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.04 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.04 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.03 | Why? |
| Australia | 2 | 2018 | 6306 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
| Probability | 1 | 2017 | 923 | 0.03 | Why? |
| Chromatography, Liquid | 1 | 2016 | 640 | 0.03 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.03 | Why? |
| Drug Prescriptions | 1 | 2021 | 1062 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Cognition | 1 | 2021 | 1394 | 0.03 | Why? |
| Feasibility Studies | 1 | 2021 | 3467 | 0.03 | Why? |
| National Health Programs | 1 | 2018 | 807 | 0.03 | Why? |
| Ebolavirus | 1 | 2018 | 834 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.03 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2016 | 1031 | 0.03 | Why? |
| United Kingdom | 2 | 2020 | 18046 | 0.02 | Why? |
| Communicable Disease Control | 1 | 2018 | 29620 | 0.02 | Why? |
| Videoconferencing | 1 | 2021 | 2081 | 0.02 | Why? |
| Cooperative Behavior | 1 | 2016 | 1216 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| Neoplasms | 1 | 2016 | 17251 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| HIV-1 | 1 | 2020 | 3365 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Primary Health Care | 1 | 2021 | 4839 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Brazil | 1 | 2018 | 12582 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.01 | Why? |
Williamson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(139)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_